Clinical Trial Update: fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

View source ↗

Summary

This document provides an update on a clinical trial evaluating fetal fibronectin testing in asymptomatic women at high risk for preterm birth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Snippet

Sponsor: Hologic, Inc. | Conditions: Pre-term Birth | Status: UNKNOWN